blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1576186

EP1576186 - METHOD FOR GENERATING A GENETICALLY MODIFIED ORGANISM FOR SCREENING ACTIVE SUBSTANCES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.03.2012
Database last updated on 15.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2011/18]
Former [2005/44]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Former [2005/38]For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / KLEBL, Bert
Imhoffstrasse 16
82294 Günzlhofen / DE
02 / STADLER, Anja
Kurt-Schumacherstrasse 18
82256 Fürstenfeldbruck / DE
03 / SÖLLNER, Rosemarie
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main / DE
04 / LEBERER, Ekkehard
Fichtenstrasse 82 B
82110 Germering / DE
05 / NITSCHE, Almut
C/O Sanofi-Aventis Deutschland GmbH
D-65926 Frankfurt am Main / DE
 [2006/51]
Former [2006/49]01 / KLEBL, Bert
Imhoffstrasse 16
82294 Günzlhofen / DE
02 / STADLER, Anja
Kurt-Schumacherstrasse 18
82256 Fürstenfeldbruck / DE
03 / SÖLLNER, Rosemarie
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main / DE
04 / LEBERER, Ekkehard
Fichtenstrasse 82 B
82110 Germering / DE
05 / NITSCHE, Almut
Emanuel-Geibelstrasse 8
65185 Wiesbaden / DE
Former [2005/38]01 / KLEBL, Bert
Imhoffstrasse 16
82294 Günzlhofen / DE
02 / STADLER, Anja
Kurt-Schumacherstrasse 18
82256 Fürstenfeldbruck / DE
03 / SÖLLNER, Rosemarie
Wurmseestrasse 60
81476 München / DE
04 / LEBERER, Ekkehard
Fichtenstrasse 82 B
82110 Germering / DE
05 / NITSCHE, Almut
Emanuel-Geibelstrasse 8
65185 Wiesbaden / DE
Application number, filing date03775367.018.11.2003
[2005/38]
WO2003EP12870
Priority number, dateDE200215888517.12.2002         Original published format: DE 10258885
[2005/38]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2004055206
Date:01.07.2004
Language:DE
[2004/27]
Type: A1 Application with search report 
No.:EP1576186
Date:21.09.2005
Language:DE
The application published by WIPO in one of the EPO official languages on 01.07.2004 takes the place of the publication of the European patent application.
[2005/38]
Type: B1 Patent specification 
No.:EP1576186
Date:04.05.2011
Language:DE
[2011/18]
Search report(s)International search report - published on:EP01.07.2004
ClassificationIPC:C12Q1/68, C12N1/00
[2005/38]
CPC:
C12N15/1086 (EP,KR,US); A01K67/033 (KR); C12N15/1072 (EP,KR,US);
C12N15/1079 (EP,KR,US); C12N15/63 (KR); C12N15/81 (EP,KR,US);
G01N33/5082 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERFAHREN ZUR GENERIERUNG EINES GENTECHNISCH VERÄNDERTEN ORGANISMUS FÜR DAS WIRKSUBSTANZSCREENING[2005/38]
English:METHOD FOR GENERATING A GENETICALLY MODIFIED ORGANISM FOR SCREENING ACTIVE SUBSTANCES[2005/38]
French:PROCEDE POUR GENERER UN ORGANISME GENETIQUEMENT MODIFIE SERVANT AU CRIBLAGE D'UNE SUBSTANCE ACTIVE[2005/38]
Entry into regional phase18.07.2005National basic fee paid 
18.07.2005Designation fee(s) paid 
18.07.2005Examination fee paid 
Examination procedure13.07.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.07.2005Examination requested  [2005/38]
10.05.2007Despatch of a communication from the examining division (Time limit: M06)
20.11.2007Reply to a communication from the examining division
12.01.2010Despatch of a communication from the examining division (Time limit: M06)
16.06.2010Reply to a communication from the examining division
19.11.2010Communication of intention to grant the patent
18.03.2011Fee for grant paid
18.03.2011Fee for publishing/printing paid
Opposition(s)07.02.2012No opposition filed within time limit [2012/15]
Fees paidRenewal fee
30.11.2005Renewal fee patent year 03
30.11.2006Renewal fee patent year 04
30.11.2007Renewal fee patent year 05
01.12.2008Renewal fee patent year 06
30.11.2009Renewal fee patent year 07
30.11.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
HU04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
TR04.05.2011
BG04.08.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
AT18.11.2011
LU18.11.2011
BE30.11.2011
MC30.11.2011
[2013/45]
Former [2013/44]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
TR04.05.2011
BG04.08.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
AT18.11.2011
LU18.11.2011
BE30.11.2011
MC30.11.2011
Former [2013/29]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
BG04.08.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
AT18.11.2011
LU18.11.2011
BE30.11.2011
MC30.11.2011
Former [2013/25]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
AT18.11.2011
LU18.11.2011
BE30.11.2011
MC30.11.2011
Former [2013/07]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
AT18.11.2011
BE30.11.2011
MC30.11.2011
Former [2012/37]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
BE30.11.2011
MC30.11.2011
Former [2012/29]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
MC30.11.2011
Former [2012/23]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
IT04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2012/10]CY04.05.2011
CZ04.05.2011
DK04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
NL04.05.2011
RO04.05.2011
SE04.05.2011
SI04.05.2011
SK04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2012/09]CY04.05.2011
CZ04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
NL04.05.2011
SE04.05.2011
SI04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2012/08]CY04.05.2011
EE04.05.2011
FI04.05.2011
IE04.05.2011
NL04.05.2011
SE04.05.2011
SI04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2012/02]CY04.05.2011
FI04.05.2011
NL04.05.2011
SE04.05.2011
SI04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2011/50]CY04.05.2011
FI04.05.2011
SE04.05.2011
SI04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2011/49]CY04.05.2011
FI04.05.2011
SE04.05.2011
GR05.08.2011
ES15.08.2011
PT05.09.2011
Former [2011/47]PT05.09.2011
Cited inInternational search[A]WO02063029  (ICONIX PHARM INC [US]) [A] 1-21* page 6, line 7 - page 7, line 7; claim - *;
 [PX]WO03016568  (VIRTEK PROTEOMICS INC [CA], et al) [PX] 1-9,11,12,15,17-21 * page 12, line 8 - page 24, line 17; claim - *;
 [X]  - TUGENDREICH STUART ET AL, "A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays", GENOME RESEARCH, (200111), vol. 11, no. 11, ISSN 1088-9051, pages 1899 - 1912, XP002272319 [X] 1-9,11,12,15,17-21 * Zusammenfassung; Diskussion; * * page 1900, column L, paragraph 2 - column R, paragraph 2 * * page 1904, column L, paragraph 2 * * page 1905, column L, paragraph 2 *
 [X]  - CAUMONT ANNE B ET AL, "Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: Potential use for inhibitor screening", CURRENT GENETICS, (1996), vol. 29, no. 6, ISSN 0172-8083, pages 503 - 510, XP002272320 [X] 1-9,11,12,15,17-21 * abstract * * Diskussion;; page 506, column R, paragraph 5 - page 507, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1007/s002940050078
 [X]  - PAUSCH M H, "G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (19971201), vol. 15, no. 12, ISSN 0167-7799, pages 487 - 494, XP004097426 [X] 1-9,11,12,15,17-21 * page 488, column R, paragraph 2 - page 491, column L, paragraph 4 *

DOI:   http://dx.doi.org/10.1016/S0167-7799(97)01119-0
 [X]  - ATIENZA J M ET AL, "Yeast Model System for Study of Mammalian Phosphodiesterases", METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC., NEW YORK, NY, US, (199801), vol. 14, no. 1, ISSN 1046-2023, pages 35 - 42, XP004466609 [X] 1-4,7-9,11,12,15,17-21 * page 35, column R, paragraph 2 - page 36, column L, paragraph 1 * * page 38, column R, paragraph 3 - page 39, column L, paragraph 1 * * page 41, column L, paragraph 2 - column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1006/meth.1997.0563
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.